Marksjarvis: Is The Market Getting Too Hot?

Hot Stocks for 2007

Still, while manias for stocks usually build over long periods of time, investors are skeptical of the recent run-up in stock prices. And that could unleash a decline if either the economy or corporate profits fall short of expectations. In a survey of global fund managers done by Bank of America Merrill Lynch this month, 68 percent said stocks are expensive. That’s the highest level since January 2002.

Biopharma’s Hot Stocks for this Week! – Earnings ESP

The proceedings are just a warm-up for a much larger trial between the two companies scheduled for March. Homeowners are doing better making their mortgage payments.Credit reporting agency TransUnion says the percentage of mortgage holders at least two months behind on their payments fell in the July-September quarter to 4.09 percent, down from 4.32 percent in the second quarter. Homeowners are benefiting from rising home values, low interest rates and stable job gains. Ethanol production has damaged land and led to more pollution, says the findings of an Associated Press investigation that includes interviews, observations and peer-reviewed research. The push to produce corn-based ethanol as part of clean energy efforts may have led to more pollution.

A Hot Year for Stocks, but Not for Hedge Funds

And picking stocks for performance within an arbitrary period of one year is hardly the best way to invest. Holding great companies for decades is a much better way to achieve market-beating returns. But can anything be learned from these yearly prognostications? I think so.

Gail MarksJarvis

Earnings ESP is our proprietary methodology for identifying stocks that have high chances of surprising with their next earnings announcement. It shows the percentage difference between the Most Accurate estimate and the Zacks Consensus Estimate. Our research shows that for stocks with this combination, the chance of a positive earnings surprise is as high as 70%. With the current earnings season on its last leg, we have chosen three biopharma stocks possessing the right combination of elements to post strong results this quarter: Medivation, Inc. ( MDVN ) is a Zacks Rank #3 stock with an earnings ESP of +10.71%.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s